Answers are grounded in this paper and cite their sources.
Examines antibacterial effects of foetidumin A derivatives against bacteria, suggesting potential therapeutic uses.
A chemical reinvestigation of the n-hexane soluble portion of the methanolic extract obtained from the leaves of Helichrysum foetidum Moench. afforded five known secondary metabolites. Foetidumin A (1), was subjected to chemical derivatizations, yielding three new semisynthetic derivative namely, (4 R) ent-3-keto-19-norbeyer-15-ene (1a), ent-3β-acetoxy-15R,16S-epoxybeyeran-19-oic acid (1b), and ent-3R,15S,16S-trihydroxybeyeran-19-oic acid (1d), along with a known ent-3β-hydroxy-15-beyeren-19-oic acid (1c). Their structures were assigned on the basis of their spectrometric (HRESIMS) and spectroscopic (1D and 2D) NMR data. Foetidumin A (1) exhibited significant activities against Pseudomonas aeruginosa (MIC = 4.7 µg/mL), Mycobacterium smegmatis and Bacillus subtilis (MIC = 9.4 µg/mL), and a moderate activity against Escherichia coli (MIC = 18.8 µg/mL), while compounds 1a and 1b exhibited moderate activities against P. aeruginosa (MIC = 75 and 37.5 µg/mL, respectively). The in silico molecular docking analysis indicated that progressive structural modification away from the reference scaffold disrupts productive binding within the 4OAD (P. aeruginosa) active site.
No takes yet. Share an insight, caveat, or question.
Nankam et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: